Author: United States. Federal Trade Commission. Bureau of Consumer ProtectionPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 390
Book Description
Drug Product Selection
Author: United States. Federal Trade Commission. Bureau of Consumer ProtectionPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 390
Book Description
Drug product selection
Author: Reasons for the Impact of Wisconsin's Drug Product Selection Law
Author: Neil J. FacchinettiPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 494
Book Description
Determination of the extent of drug product selection legislation in Texas chain store pharmacies
Author: Petcharat PongcharoensukPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 150
Book Description
Generic Drug Laws
Author: Theodore GoldbergPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 584
Book Description
Evaluation of the Impact of Florida's Drug Product Selection Law
Author: George Joseph VuturoPublisher:
ISBN:
Category :
Languages : en
Pages : 394
Book Description
Brand Substitution Law in Wisconsin
Author: Paul Arthur HolbergPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 630
Book Description
Drug Product Selection
Author: United States. Federal Trade Commission. Bureau of Consumer ProtectionPublisher:
ISBN:
Category : Drug traffic
Languages : en
Pages : 361
Book Description
A Study of Physician Acceptance of a Prescription Pharmaceutical Innovation Within a Selected Oregon Community
Author: William Howard CampbellPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 170
Book Description
An investigation concerning the acceptance of a new, legend drug product was conducted within a community of 15,000 population. Twenty-eight physicians within the community were chosen for evaluation relative to acceptance of the new drug product. Data were obtained by means of a prescription audit of nine retail pharmacies in the community. The time period of the audit consisted of three months prior, and nine months subsequent, to the introduction of the new drug product. A descriptive analysis of the selected pharmaceutical market indicated a seasonal variation in utilization of the class of drug products to which the new drug product belonged. A high degree of substitutability was also indicated for drug products within the special class. A rank-order analysis indicated physician general prescribing frequency and physician class prescribing frequency were positively correlated. Definitions of acceptance of the new drug product were constructed by means of objective criteria. These criteria were implemented by utilizing physician prescribing records, market share information, and a linear, least squares regression equation. Certain physician characteristics were found to be positively correlated with early acceptance of the new drug product. These characteristics pertained to class prescribing frequency, general prescribing frequency, and medical school alma mater location. Pharmacists within the community were selected for evaluation as an alternate source of market information. A mail questionnaire was constructed and from its responses eight physician classifications were established. Six of the classifications were positively correlated with early acceptance of the new drug product. The strengths of correlation of two questionnaire classifications were equal to the strongest correlation achieved using prescription audit data.
Author: